Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CLCA1 | Human | 1,2-dichloroethane | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of CLCA1 mRNA | CTD | PMID:28960355 | CLCA1 | Human | 17alpha-ethynylestradiol | increases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of CLCA1 mRNA | CTD | PMID:17557909 | CLCA1 | Human | 17beta-estradiol | multiple interactions | ISO | Clca1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of CLCA1 mRNA more ... | CTD | PMID:26496021 more ... | CLCA1 | Human | 17beta-estradiol | affects expression | ISO | Clca1 (Mus musculus) | 6480464 | Estradiol affects the expression of CLCA1 mRNA | CTD | PMID:15598610 | CLCA1 | Human | 17beta-estradiol | increases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | Estradiol results in increased expression of CLCA1 mRNA | CTD | PMID:26945725 and PMID:32145629 | CLCA1 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Clca1 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA1 mRNA | CTD | PMID:32741896 | CLCA1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CLCA1 mRNA | CTD | PMID:19933214 | CLCA1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Clca1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CLCA1 mRNA | CTD | PMID:18691609 | CLCA1 | Human | 2,4,6-trinitrobenzenesulfonic acid | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of CLCA1 mRNA | CTD | PMID:17982090 | CLCA1 | Human | 2-butoxyethanol | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | n-butoxyethanol results in increased expression of CLCA1 mRNA | CTD | PMID:19812364 | CLCA1 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of CLCA1 mRNA | CTD | PMID:24780913 | CLCA1 | Human | 7,12-dimethyltetraphene | decreases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | 9 more ... | CTD | PMID:19480007 | CLCA1 | Human | aflatoxin B1 | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of CLCA1 mRNA | CTD | PMID:19770486 | CLCA1 | Human | all-trans-retinoic acid | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CLCA1 mRNA | CTD | PMID:36189433 | CLCA1 | Human | apigenin | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Apigenin results in decreased expression of CLCA1 mRNA | CTD | PMID:22359648 | CLCA1 | Human | Aroclor 1254 | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CLCA1 mRNA | CTD | PMID:23650126 | CLCA1 | Human | arsane | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Arsenic results in decreased expression of CLCA1 mRNA | CTD | PMID:19654921 | CLCA1 | Human | arsane | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Arsenic results in increased expression of CLCA1 mRNA and Arsenic results in increased expression of CLCA1 protein | CTD | PMID:22552367 and PMID:23221970 | CLCA1 | Human | arsenic atom | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Arsenic results in decreased expression of CLCA1 mRNA | CTD | PMID:19654921 | CLCA1 | Human | arsenic atom | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Arsenic results in increased expression of CLCA1 mRNA and Arsenic results in increased expression of CLCA1 protein | CTD | PMID:22552367 and PMID:23221970 | CLCA1 | Human | benzo[a]pyrene | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CLCA1 mRNA | CTD | PMID:22228805 | CLCA1 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CLCA1 promoter | CTD | PMID:27901495 | CLCA1 | Human | Benzo[ghi]perylene | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | 1 and 12-benzoperylene results in increased expression of CLCA1 mRNA | CTD | PMID:26377693 | CLCA1 | Human | beta-damascenone | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | beta-damascenone results in increased expression of CLCA1 mRNA | CTD | PMID:22982537 | CLCA1 | Human | bisphenol A | multiple interactions | ISO | Clca1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in increased expression of CLCA1 mRNA | CTD | PMID:26496021 | CLCA1 | Human | bisphenol A | decreases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CLCA1 mRNA | CTD | PMID:25181051 | CLCA1 | Human | buta-1,3-diene | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | 1 and 3-butadiene results in increased expression of CLCA1 mRNA | CTD | PMID:29038090 | CLCA1 | Human | calcium silicate | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | calcium silicate results in increased expression of CLCA1 mRNA | CTD | PMID:29279043 | CLCA1 | Human | carbon monoxide | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CLCA1 mRNA | CTD | PMID:29621558 | CLCA1 | Human | carbon nanotube | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 and PMID:27106021 | CLCA1 | Human | carbon nanotube | affects expression | ISO | Clca1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CLCA1 | Human | carnosic acid | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | salvin results in increased expression of CLCA1 protein | CTD | PMID:35926579 | CLCA1 | Human | ceric oxide | multiple interactions | EXP | | 6480464 | [Antigens and Dermatophagoides co-treated with ceric oxide] results in increased expression of CLCA1 mRNA | CTD | PMID:29792201 | CLCA1 | Human | ceric oxide | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [Antigens more ... | CTD | PMID:29792201 | CLCA1 | Human | chloroprene | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Chloroprene results in increased expression of CLCA1 mRNA | CTD | PMID:23125180 | CLCA1 | Human | chlorpyrifos | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of CLCA1 mRNA | CTD | PMID:37019170 | CLCA1 | Human | chromium(6+) | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | chromium hexavalent ion results in increased expression of CLCA1 protein | CTD | PMID:22552367 | CLCA1 | Human | ciguatoxin CTX1B | affects expression | ISO | Clca1 (Mus musculus) | 6480464 | Ciguatoxins affects the expression of CLCA1 mRNA | CTD | PMID:18353800 | CLCA1 | Human | copper atom | multiple interactions | ISO | Clca1 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of CLCA1 mRNA | CTD | PMID:26033743 | CLCA1 | Human | copper(0) | multiple interactions | ISO | Clca1 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of CLCA1 mRNA | CTD | PMID:26033743 | CLCA1 | Human | crocidolite asbestos | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Asbestos and Crocidolite results in increased expression of CLCA1 mRNA | CTD | PMID:29279043 | CLCA1 | Human | Cuprizon | increases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of CLCA1 mRNA | CTD | PMID:26577399 | CLCA1 | Human | dextran sulfate | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCA1 mRNA | CTD | PMID:29950665 | CLCA1 | Human | dibutyl phthalate | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of CLCA1 mRNA | CTD | PMID:21266533 | CLCA1 | Human | diethylstilbestrol | increases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | Diethylstilbestrol results in increased expression of CLCA1 mRNA | CTD | PMID:21658437 | CLCA1 | Human | diethylstilbestrol | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of CLCA1 mRNA | CTD | PMID:17394237 | CLCA1 | Human | doxorubicin | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Doxorubicin results in increased expression of CLCA1 mRNA | CTD | PMID:21040762 | CLCA1 | Human | doxorubicin | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of CLCA1 mRNA | CTD | PMID:21040762 | CLCA1 | Human | Erionite | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | erionite results in increased expression of CLCA1 mRNA | CTD | PMID:29279043 | CLCA1 | Human | ferroheme b | decreases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | Heme results in decreased expression of CLCA1 mRNA | CTD | PMID:15539406 | CLCA1 | Human | folic acid | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of CLCA1 mRNA | CTD | PMID:25629700 | CLCA1 | Human | formaldehyde | decreases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | Formaldehyde results in decreased expression of CLCA1 mRNA | CTD | PMID:24304932 | CLCA1 | Human | furan | increases methylation | ISO | Clca1 (Rattus norvegicus) | 6480464 | furan results in increased methylation of CLCA1 gene | CTD | PMID:22079235 | CLCA1 | Human | furan | increases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | furan results in increased expression of CLCA1 mRNA | CTD | PMID:27387713 | CLCA1 | Human | genistein | increases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | Genistein results in increased expression of CLCA1 mRNA | CTD | PMID:17341692 | CLCA1 | Human | heme b | decreases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | Heme results in decreased expression of CLCA1 mRNA | CTD | PMID:15539406 | CLCA1 | Human | histamine | increases expression | EXP | | 6480464 | Histamine results in increased expression of CLCA1 mRNA | CTD | PMID:17622767 | CLCA1 | Human | hydrogen peroxide | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [Hydrogen Peroxide co-treated with N-(oxo-5 more ... | CTD | PMID:31494107 | CLCA1 | Human | isoprenaline | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of CLCA1 mRNA | CTD | PMID:20003209 | CLCA1 | Human | maneb | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of CLCA1 mRNA and Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of CLCA1 mRNA] | CTD | PMID:23963992 | CLCA1 | Human | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in decreased expression of CLCA1 mRNA | CTD | PMID:36189433 | CLCA1 | Human | naphthalene | increases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | naphthalene analog results in increased expression of CLCA1 mRNA | CTD | PMID:24976557 | CLCA1 | Human | ozone | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Ozone results in increased expression of CLCA1 mRNA | CTD | PMID:28891433 | CLCA1 | Human | ozone | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Ozone results in decreased expression of CLCA3 mRNA | CTD | PMID:33026818 | CLCA1 | Human | ozone | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CLCA1 mRNA | CTD | PMID:26203683 more ... | CLCA1 | Human | paraquat | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of CLCA1 mRNA and Silymarin inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of CLCA1 mRNA] | CTD | PMID:23963992 | CLCA1 | Human | phenobarbital | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of CLCA1 mRNA] | CTD | PMID:19482888 | CLCA1 | Human | phenobarbital | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of CLCA1 mRNA | CTD | PMID:19482888 | CLCA1 | Human | pirinixic acid | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CLCA1 mRNA | CTD | PMID:18445702 | CLCA1 | Human | potassium dichromate | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of CLCA1 mRNA | CTD | PMID:23608068 | CLCA1 | Human | progesterone | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Progesterone results in decreased expression of CLCA1 mRNA | CTD | PMID:22238285 | CLCA1 | Human | progesterone | affects expression | ISO | Clca1 (Mus musculus) | 6480464 | Progesterone affects the expression of CLCA1 mRNA | CTD | PMID:17251523 | CLCA1 | Human | resveratrol | decreases expression | EXP | | 6480464 | Resveratrol results in decreased expression of CLCA1 protein | CTD | PMID:26549244 | CLCA1 | Human | resveratrol | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | Resveratrol inhibits the reaction [OVAL protein results in increased expression of CLCA1 protein] | CTD | PMID:26549244 | CLCA1 | Human | serpentine asbestos | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Asbestos more ... | CTD | PMID:16251409 | CLCA1 | Human | silicon dioxide | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of CLCA1 mRNA | CTD | PMID:29341224 | CLCA1 | Human | sodium arsenite | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of CLCA1 mRNA | CTD | PMID:17350061 | CLCA1 | Human | sodium arsenite | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CLCA1 mRNA | CTD | PMID:37682722 | CLCA1 | Human | sodium fluoride | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of CLCA3 mRNA | CTD | PMID:27862939 | CLCA1 | Human | sulfur dioxide | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Carbon Monoxide co-treated with Nitrogen Oxides co-treated with Sulfur Dioxide]] which results in increased expression of CLCA1 mRNA | CTD | PMID:29621558 | CLCA1 | Human | tamoxifen | affects expression | ISO | Clca1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of CLCA1 mRNA | CTD | PMID:20937368 | CLCA1 | Human | testosterone | multiple interactions | ISO | Clca1 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CLCA1 mRNA | CTD | PMID:32741896 | CLCA1 | Human | tetrachloromethane | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CLCA1 mRNA | CTD | PMID:17484886 | CLCA1 | Human | titanium dioxide | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of CLCA1 mRNA | CTD | PMID:27760801 | CLCA1 | Human | titanium dioxide | multiple interactions | ISO | Clca1 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CLCA1 mRNA | CTD | PMID:29950665 | CLCA1 | Human | titanium dioxide | increases expression | ISO | Clca1 (Rattus norvegicus) | 6480464 | titanium dioxide results in increased expression of CLCA1 mRNA | CTD | PMID:30012374 | CLCA1 | Human | titanium dioxide | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of CLCA1 mRNA | CTD | PMID:23131501 and PMID:23557971 | CLCA1 | Human | tremolite asbestos | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | tremolite results in increased expression of CLCA1 mRNA | CTD | PMID:29279043 | CLCA1 | Human | trimellitic anhydride | increases expression | ISO | Clca1 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of CLCA1 mRNA | CTD | PMID:16141432 | CLCA1 | Human | vancomycin | decreases expression | ISO | Clca1 (Mus musculus) | 6480464 | Vancomycin results in decreased expression of CLCA1 mRNA | CTD | PMID:18930951 | |